Editor-in-Chief Sue Yom hosts a British-American conversation about brachytherapy. Guests include Dr. Mahbuba Choudhury, Clinical Oncology Registrar and Stereotactic Radiotherapy Fellow at Imperial College London NHS Trust, and Dr. Imtiaz Ahmed, Consultant Clinical Oncologist and Clinical Lead at Southend University Hospital in the UK, first and supervising authors on this month’s paper,
Timing of High-Dose Rate Brachytherapy with External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate Cancer Patients and Its Effects on Toxicity and Quality of Life: A Randomized Controlled Trial), as well as Dr. Akila Viswanathan, Professor and Chair of the Department of Radiation Oncology at Johns Hopkins University, supervising author of two papers publishing together this month, Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.: A Surveillance, Epidemiology, and End-Results Study) and Updated Trends in Brachytherapy Utilization and Disparities in the United States from 2004 to 2020).
